Follow
Cancer genomic profiling
Cancer genomic profiling is a laboratory technique used in the generation of personalized medicine. The genomic profiling evaluates all the genes present in tumor to determine an optimal course of treatment for an individual.
-
NOV 16, 2016 | 8:00 AM
DATE: November 16, 2016 TIME: 8:00am PT, 11:00am ET Breast cancer is the most commonly diagnosed cancer in women and is the second leading cause of cancer death among wo...NOV 04, 2016 | 10:00 AM
DATE: November 4, 2016 TIME: 10:00am PT, 1:00pm ET How do you develop clinically relevant biomarkers? Systematic tumor profiling with multi-omics tools and rapid analytical...Speaker: Antonia Sepulveda, MD, PhD , Yang Yang, PhD , Tamara Lotan, MDSponsored By: Affymetrix, AffymetrixNOV 02, 2016 | 1:30 PM
Today there are about 7B mobile phone worldwide and about 50,000 mobile health applications actively changing the landscape of how healthcare will be delivered in the next years. While numero...Speaker: John McDevitt, PhDOCT 06, 2016 | 7:30 AM
Intra-tumor heterogeneity is a major obstacle to cancer treatment. Existing single-cell studies of intra-tumor heterogeneity have largely focused on DNA mutations; functional heterogeneity is...Speaker: Shyam Prabhakar, PhDMAY 12, 2016 | 12:00 PM
In order to realize the benefits of personalized cancer therapy, increasing demands are placed upon clinical laboratories to provide timely, comprehensive, clinically actionable, and analytic...MAY 11, 2016 | 1:30 PMC.E. CREDITS
Human breast tumors have been shown to exhibit extensive inter- and intra-tumor heterogeneity. While recent advances in genomic technologies have allowed us to deconvolute this heterogeneity,...Speaker: Ioannis (Jiannis) Ragoussis, PhDPresented at: Genetics and Genomics Virtual Event Series 2016
MAY 11, 2016 | 1:30 PM
The clinical utility of high-dimensional molecular profiling has been provisionally established in several domains of medicine. Today, interrogation of scores of genes and even whole ex...APR 07, 2016 | 10:00 AM
The Personalized Medicine Initiative (PMI) is a non-profit enterprise based in Vancouver, Canada that is focused on introducing personalized, molecularly-based medicine into the front lines o...APR 07, 2016 | 7:30 AM
Oncologists and pathologists are increasingly utilizing information on genomic alterations in tumors to help guide patient care and treatment. Personalis, Inc., a genomic sequencing and inter...MAR 29, 2016 | 8:00 AM
Recent advances in next-generation sequencing (NGS) have helped to accelerate the pace of discovery in the field of genetic disease research and testing. The ability to analyze multiple genes...Speaker: Brian Meyer, PhD , Robert Sebra, PhDFEB 24, 2016 | 11:00 AM
Cell death is involved in diseases such as cancer and neurodegeneration, and also has a natural role in the development of multicellular organisms. Although apoptosis has been well defined, a...FEB 24, 2016 | 8:00 AM
One of the primary goals of precision medicine is the aggregation and interpretation of deep, longitudinal patient-specific data in the context of the digital universe of information, using a...FEB 24, 2016 | 7:00 AM
A number of recently publications have heralded the advent of Precision Medicine in Oncology, where next generation sequencing technology, other ’omics technologies, serial biopsies, so...SEP 30, 2015 | 6:00 AM
The genome determines changes of the transcription profile upon environmental changes and finally determines how a cell reacts. A comparative genome and transcriptome analysis of the same sam...Speaker: Christian Korfhage, PhDSEP 09, 2015 | 9:00 AM
DATE: September 9, 2015TIME: 9:00am PDT, 12:00PM EDTDriver mutations are causally implicated in tumorigenesis and disease progression, and they are defined by molecular abnormalities such as ...JUN 17, 2015 | 8:00 AM
DATE: June 17th, 2015TIME: 8am Pacific time, 11am Eastern timeSpatial heterogeneity of tumors has been identified within and between metastatic lesions and can be visualized wit...MAY 14, 2015 | 1:30 PM
Asthma is heritable, influenced by the environment, and is modified by in utero exposures and aging; all of these features are also common to epigenetic regulation. Furthermore, genetic varia...MAY 14, 2015 | 7:30 AM
I will discuss the use of genomic technologies - mostly ultrahigh-throughput DNA sequencing - to study normal human biology and to determine what goes wrong when we have disease. First I wil...MAY 13, 2015 | 6:00 AM
Cancers exhibit abnormal molecular signatures associated with disease initiation and progression. Molecular signatures could improve cancer screening, detection, drug development and selectio...OCT 30, 2014 | 10:30 AM
Uncovering the genetic lesions underpinning cancer through genomic profiling in a clinical setting could provide insights into possible treatment options for oncologists and their patients. N...Speaker: John Carpten, PhDOCT 29, 2014 | 7:30 AM
The effective implementation of personalised cancer therapeutic regimens depends on the successful identification and translation of informative biomarkers to aid clinical decision-making. An...Speaker: Darran O'Connor, PhDAUG 21, 2014 | 9:30 AM
Next-Generation Sequencing is enabling scientists to study the transcriptome in ways never before possible. During this session with Illumina Distinguished Scientist, Dr. Gary Schroth, you w...NOV 08, 2013 | 12:00 PM
The NCI's Therapeutically Applicable Research to Generate Effective Treatments (TARGET) is a comprehensive genomic characterization initiative to determine the molecular changes that drive th...Speaker: Jaime Guidry Auvil, PhDOCT 17, 2013 | 11:00 AMC.E. CREDITS
Curative therapy for metastatic disease in solid malignancies remains frustratingly elusive due to the long recognized problem of tumor cell heterogeneity and emergence of treatment resistant...Speaker: George Poste, DVM, DSc, PhD
NOV 16, 2016 | 8:00 AM
DATE: November 16, 2016
TIME: 8:00am PT, 11:00am ET
Breast cancer is the most commonly diagnosed cancer in women and is the second leading cause of cancer death among wo...
NOV 04, 2016 | 10:00 AM
DATE: November 4, 2016
TIME: 10:00am PT, 1:00pm ET
How do you develop clinically relevant biomarkers?
Systematic tumor profiling with multi-omics tools and rapid analytical...
Speaker:
Antonia Sepulveda, MD, PhD
, Yang Yang, PhD
, Tamara Lotan, MD
Sponsored By: Affymetrix,
Affymetrix
NOV 02, 2016 | 1:30 PM
Today there are about 7B mobile phone worldwide and about 50,000 mobile health applications actively changing the landscape of how healthcare will be delivered in the next years. While numero...
Speaker:
John McDevitt, PhD
OCT 06, 2016 | 7:30 AM
Intra-tumor heterogeneity is a major obstacle to cancer treatment. Existing single-cell studies of intra-tumor heterogeneity have largely focused on DNA mutations; functional heterogeneity is...
Speaker:
Shyam Prabhakar, PhD
MAY 12, 2016 | 12:00 PM
In order to realize the benefits of personalized cancer therapy, increasing demands are placed upon clinical laboratories to provide timely, comprehensive, clinically actionable, and analytic...
MAY 11, 2016 | 1:30 PM
C.E. CREDITS
Human breast tumors have been shown to exhibit extensive inter- and intra-tumor heterogeneity. While recent advances in genomic technologies have allowed us to deconvolute this heterogeneity,...
Speaker:
Ioannis (Jiannis) Ragoussis, PhD
Presented at: Genetics and Genomics Virtual Event Series 2016
MAY 11, 2016 | 1:30 PM
The clinical utility of high-dimensional molecular profiling has been provisionally established in several domains of medicine. Today, interrogation of scores of genes and even whole ex...
APR 07, 2016 | 10:00 AM
The Personalized Medicine Initiative (PMI) is a non-profit enterprise based in Vancouver, Canada that is focused on introducing personalized, molecularly-based medicine into the front lines o...
APR 07, 2016 | 7:30 AM
Oncologists and pathologists are increasingly utilizing information on genomic alterations in tumors to help guide patient care and treatment. Personalis, Inc., a genomic sequencing and inter...
MAR 29, 2016 | 8:00 AM
Recent advances in next-generation sequencing (NGS) have helped to accelerate the pace of discovery in the field of genetic disease research and testing. The ability to analyze multiple genes...
Speaker:
Brian Meyer, PhD
, Robert Sebra, PhD
FEB 24, 2016 | 11:00 AM
Cell death is involved in diseases such as cancer and neurodegeneration, and also has a natural role in the development of multicellular organisms. Although apoptosis has been well defined, a...
FEB 24, 2016 | 8:00 AM
One of the primary goals of precision medicine is the aggregation and interpretation of deep, longitudinal patient-specific data in the context of the digital universe of information, using a...
FEB 24, 2016 | 7:00 AM
A number of recently publications have heralded the advent of Precision Medicine in Oncology, where next generation sequencing technology, other ’omics technologies, serial biopsies, so...
SEP 30, 2015 | 6:00 AM
The genome determines changes of the transcription profile upon environmental changes and finally determines how a cell reacts. A comparative genome and transcriptome analysis of the same sam...
Speaker:
Christian Korfhage, PhD
SEP 09, 2015 | 9:00 AM
DATE: September 9, 2015TIME: 9:00am PDT, 12:00PM EDTDriver mutations are causally implicated in tumorigenesis and disease progression, and they are defined by molecular abnormalities such as ...
JUN 17, 2015 | 8:00 AM
DATE: June 17th, 2015TIME: 8am Pacific time, 11am Eastern timeSpatial heterogeneity of tumors has been identified within and between metastatic lesions and can be visualized wit...
MAY 14, 2015 | 1:30 PM
Asthma is heritable, influenced by the environment, and is modified by in utero exposures and aging; all of these features are also common to epigenetic regulation. Furthermore, genetic varia...
MAY 14, 2015 | 7:30 AM
I will discuss the use of genomic technologies - mostly ultrahigh-throughput DNA sequencing - to study normal human biology and to determine what goes wrong when we have disease. First I wil...
MAY 13, 2015 | 6:00 AM
Cancers exhibit abnormal molecular signatures associated with disease initiation and progression. Molecular signatures could improve cancer screening, detection, drug development and selectio...
OCT 30, 2014 | 10:30 AM
Uncovering the genetic lesions underpinning cancer through genomic profiling in a clinical setting could provide insights into possible treatment options for oncologists and their patients. N...
Speaker:
John Carpten, PhD
OCT 29, 2014 | 7:30 AM
The effective implementation of personalised cancer therapeutic regimens depends on the successful identification and translation of informative biomarkers to aid clinical decision-making. An...
Speaker:
Darran O'Connor, PhD
AUG 21, 2014 | 9:30 AM
Next-Generation Sequencing is enabling scientists to study the transcriptome in ways never before possible. During this session with Illumina Distinguished Scientist, Dr. Gary Schroth, you w...
NOV 08, 2013 | 12:00 PM
The NCI's Therapeutically Applicable Research to Generate Effective Treatments (TARGET) is a comprehensive genomic characterization initiative to determine the molecular changes that drive th...
Speaker:
Jaime Guidry Auvil, PhD
OCT 17, 2013 | 11:00 AM
C.E. CREDITS
Curative therapy for metastatic disease in solid malignancies remains frustratingly elusive due to the long recognized problem of tumor cell heterogeneity and emergence of treatment resistant...
Speaker:
George Poste, DVM, DSc, PhD